Treatment of micropapillary carcinoma of the thyroid: Where do we draw the line?

Thyroid

Volumn 17, Issue 11, 2007, Pages 1093-1096

  McDougall, I Ross ^a,b   Camargo, Carlos A ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CASE REPORT; CONSULTATION; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPERPARATHYROIDISM; LYMPHOCYTIC THYROIDITIS; MALE; PAPILLARY CARCINOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY; THYROID CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL;

ADULT; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 36749047926     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0203     Document Type: Article

References (30)

1. Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI 2006 Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16(12):1229-1242.
2. Hay ID 2006 Selective use of radioactive iodine in the post-operative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol 94(8):692-700.
3. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B, Limbert E, Lind P, Pacini F, Reiners C, Sanchez Franco F, Toft A, Wiersinga WM 2004 Follow-up of low-risk patients with differentiated thyroid carcinoma; a European perspective. Eur J Endocrinol 150(2):105-112.
4. Mazzaferri E, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418-428.
5. Mazzaferri EL, Massoll N 2002 Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer 9(4):227-247.
6. Sakorafas GH, Giotakis J, Stafyla V 2005 Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev 31(6):423-438.
7. Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED 2003 Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol 11(4):249-251.
8. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A 2003 An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13(4):381-387.
9. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A 2004 Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28(11):1115-1121.
10. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ 1992 Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112(6):1139-1146; discussion 1146-1147.
11. Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE, Degli Uberti EC 2006 Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 91(6):2171-2178.
12. Bramley MD, Harrison BJ 1996 Papillary microcarcinoma of the thyroid gland. Br J Surg 83(12):1674-1683.
13. Rodriguez JM, Moreno A, Parrilla P, Sola J, Soria T, Tebar FJ, Arando F 1997 Papillary thyroid microcarcinoma: clinical study and prognosis. Eur J Surg 163(4):255-259.
14. Lin KD, Lin JD, Huang HS, Jeng LB, Ho YS 1997 Skull metastasis with brain invasion from thyroid papillary microcarcinoma. J Formos Med Assoc 96(4):280-282.
15. Sugitani I, Yanagisawa A, Shimizu A, Kato M, Fujimoto Y 1998 Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg 22(7):731-737.
16. Nasir A, Chaudhry AZ, Gillespie J, Kaiser HE 2000 Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review. In Vivo 14(2):367-376.
17. Lin KD, Lin JD, Huang MJ, Huang HS, Jeng LB, Chao TC, Ho YS 1997 Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int Surg 82(4):378-381.
18. Sugitani I, Fujimoto Y 1999 Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J 46(1):209-216.
19. Barbaro D, Simi U, Meucci G, Lapi P, Orsini P, Pasquini C 2005 Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and non-incidental cancers - are they different diseases? Clin Endocrinol (Oxf) 63(5):577-581.
20. Siegler M 1975 Pascal's wager and the hanging of crepe. N Engl J Med 293(17):853-857.
21. Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L 1995 Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 36(1):21-27.
22. Glanzmann C 1992 Subsequent malignancies in patients treated with 131-iodine for thyroid cancer. Strahlenther Onkol 168(6):337-343.
23. de Vathaire F, Schlumberger M, Delisle MJ, Francese C, Challeton C, de la Genardiere E, Meunier F, Parmentier C, Hill C, Sancho-Garnier H 1997 Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 75(5):734-739.
24. Sandeep TC, Strachan MW, Reynolds RM, Brewster DH, Scelo G, Pukkala E, Hemminki K, Anderson A, Tracey E, Friis S, McBride ML, Kee-Seng C, Pompe-Kim V, Kliewer EV, Tonita JM, Jonasson JG, Martos C, Boffetta P, Brennan P 2006 Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab 91(5):1819-1825.
25. Alexander C, Bader JB, Schaefer A, Fincke C, Kirsch C-M 1998 Intermediate and long-term side effects of high-dose radio-iodine therapy for thyroid carcinoma. J Nucl Med 39:1551-1554.
26. Zettinig G, Hanselmayer G, Fueger BJ, Hofmann A, Pirich C, Nepp J, Dudczak R 2002 Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study. Eur J Nucl Med Mol Imaging 29(11):1428-1432.
27. Kloos RT, Duvuuri V, Jhiang SM, Cahill KV, Foster JA, Burns JA 2002 Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab 87(12):5817-5820.
28. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, Mclver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16(2):109-142.
29. Sakorafas GH, Stafyla V, Kolettis T, Tolumis G, Kassaras G, Peros G 2007 Microscopic papillary thyroid cancer as an incidental finding in patients treated surgically for presumably benign thyroid disease. J Postgrad Med 53(1):23-26.
30. Pelizzo MR, Boschin IM, Toniato A, Pagetta C, Piotto A, Bernante P, Casara D, Pennelli G, Rubello D 2004 Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl Med Commun 25(6):547-552.